Asia Pacific Blood Plasma Derivatives Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)

No. of Pages: 158    |    Report Code: BMIRE00028461    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Blood Plasma Derivatives Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Blood Plasma Derivatives Market – by Type

1.3.2        Asia Pacific Blood Plasma Derivatives Market – by Application

1.3.3        Asia Pacific Blood Plasma Derivatives Market – by End User

1.3.4        Asia Pacific Blood Plasma Derivatives Market – by Country

2.           Asia Pacific Blood Plasma Derivatives Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Blood Plasma Derivatives Market – Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Expert’s Opinion

5.           Asia Pacific Blood Plasma Derivatives Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Prevalence of Blood Disorders

5.1.2        Rise in Geriatric Population

5.2         Market Restraints

5.2.1        Complicated Reimbursement Policies

5.3         Market Opportunities

5.3.1        Incorporation of Platelet-Rich Plasma in Regenerative Medicine

5.4         Future Trends

5.4.1        Increasing Usage of Immunoglobulin G in Multiple Treatments

5.5         Impact Analysis

6.           Blood Plasma Derivatives Market – Asia Pacific Analysis

6.1         Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.           Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type

7.1         Overview

7.2         Asia Pacific Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

7.3         Albumin

7.3.1        Overview

7.3.2        Albumin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Factor VIII

7.4.1        Overview

7.4.2        Factor VIII: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Factor IX

7.5.1        Overview

7.5.2        Factor IX: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Immunoglobulin

7.6.1        Overview

7.6.2        Immunoglobulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.3        IgG

7.6.3.1          Overview

7.6.3.2          IgG: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.4        IgM

7.6.4.1          Overview

7.6.4.2          IgM: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.5        IgA

7.6.5.1          Overview

7.6.5.2          IgA: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.6        IgD

7.6.6.1          Overview

7.6.6.2          IgD: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.7        IgE

7.6.7.1          Overview

7.6.7.2          IgE: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Hyperimmune Globulin

7.7.1        Overview

7.7.2        Hyperimmune Globulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application

8.1         Overview

8.2         Asia Pacific Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

8.3         Hemophilia

8.3.1        Overview

8.3.2        Hemophilia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Hypogammaglobulinemia

8.4.1        Overview

8.4.2        Hypogammaglobulinemia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Immunodeficiency Diseases

8.5.1        Overview

8.5.2        Immunodeficiency Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Von Willebrand Disease

8.6.1        Overview

8.6.2        Von Willebrand Disease: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Other Applications

8.7.1        Overview

8.7.2        Other Applications: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User

9.1         Overview

9.2         Asia Pacific Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Other End Users

9.5.1        Overview

9.5.2        Other End Users: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     Asia Pacific: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)

10.1.1.1       Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Australia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.1.3.1     Australia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.1.4       Australia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5       Australia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.2       China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       China: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.2.3.1     China: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.2.4       China: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5       China Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.3       India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       India: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.3.3.1     India: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.3.4       India: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5       India Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.4       Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Japan: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.4.3.1     Japan: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.4.4       Japan: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.4.5       Japan Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.5       South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       South Korea: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.5.3.1     South Korea: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.5.4       South Korea: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.5.5       South Korea Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.6       Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.6.3.1     Rest of Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.6.4       Rest of Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.6.5       Rest of Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Blood Plasma Derivatives Market

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Company Profiles

12.1      Grifols SA

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      SK Plasma Co Ltd

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Octapharma AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Monobind Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Intas Pharmaceuticals Ltd

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Fusion Health Care Pvt Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Takeda Pharmaceutical Co Ltd

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      CSL Behring LLC

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      LFB SA

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Kedrion SpA

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

LIST OF TABLES

Table 1.             Australia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Australia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Australia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Australia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 7.             China Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             China Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             India Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          India Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 11.          India Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12.          India Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Japan Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Japan Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Japan Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Japan Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          South Korea Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 18.          South Korea Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 19.          South Korea Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20.          South Korea Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Rest of Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market

Table 26.          Recent Organic Growth Strategies in the Blood Plasma Derivatives Market

Table 27.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Asia Pacific Blood Plasma Derivatives Market Segmentation

Figure 2.           Asia Pacific Blood Plasma Derivatives Market, by Country

Figure 3.           Asia Pacific Blood Plasma Derivatives Market Overview

Figure 4.           Immunoglobulin Segment Held Largest Share of Type Segment in Asia Pacific Blood Plasma Derivatives Market

Figure 5.           India is Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Asia Pacific Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        Asia Pacific Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

Figure 11.        Albumin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Factor VIII: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Factor IX: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Immunoglobulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        IgG: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        IgM: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        IgA: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        IgD: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        IgE: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Hyperimmune Globulin: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Asia Pacific Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

Figure 23.        Hemophilia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Hypogammaglobulinemia: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Immunodeficiency Diseases: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Von Willebrand Disease: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other Applications: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Asia Pacific Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

Figure 29.        Hospitals: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Clinics: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Other End Users: Asia Pacific Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Asia Pacific: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33.        Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Growth Strategies in the Blood Plasma Derivatives Market

 

The List of Companies - Asia Pacific Blood Plasma Derivatives Market

  1. Grifols SA
  2. SK Plasma Co Ltd
  3. Octapharma AG
  4. Monobind Inc.
  5. Intas Pharmaceuticals Ltd
  6. Takeda Pharmaceutical Co Ltd
  7. CSL Behring LLC
  8. LFB SA
  9. Kedrion SpA
  10. Fusion Health Care Pvt Ltd